| Literature DB >> 17615234 |
Sjoerd H van der Burg1, Sytse J Piersma, Annemieke de Jong, Jeanette M van der Hulst, Kitty M C Kwappenberg, Muriel van den Hende, Marij J P Welters, Jon J Van Rood, Gert Jan Fleuren, Cornelis J M Melief, Gemma G Kenter, Rienk Offringa.
Abstract
Because of their important role in the maintenance of self-tolerance, CD4(+) regulatory T cells prevent autoimmune diseases but also curtail the efficacy of T cell immune responses against cancers. We now show that this suppressive action of CD4(+) regulatory T cells is not limited to cancers displaying tumor-associated self antigens, such as melanomas, but also extends to human papillomavirus (HPV)-positive cervical cancers that express foreign tumor antigens. HPV-specific CD4(+) T cells isolated from lymph node biopsies of cervical cancer patients were found to suppress proliferation and cytokine (IFN-gamma, IL-2) production by responder T cells. The capacity of HPV-specific CD4(+) T cells to exert this suppressive effect depended on their activation by cognate HPV antigen and on close-range interactions with responder T cells. HPV-specific CD4(+) regulatory T cells were also retrieved from cervical cancer biopsies, suggesting that they interfere with the anti-tumor immune response at both the induction and effector levels. Our findings offer a plausible explanation for the observed failure of the tumor-specific immune response in patients with cervical carcinoma.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17615234 PMCID: PMC1924590 DOI: 10.1073/pnas.0704672104
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205